Formulations of phospholipase enzyme inhibitors

A technology of active agent and solubilizer, applied in anti-inflammatory agents, non-central analgesics, non-active ingredients of oil/fat/wax, etc., can solve problems such as unpurified proteins

Inactive Publication Date: 2009-11-04
WYETH LLC
View PDF14 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But the protein was not purified to homogeneity [see C.C. Leslie et al., Biochem. Biophys. Acta., 963: 476-492 (1988)]

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Formulations of phospholipase enzyme inhibitors
  • Formulations of phospholipase enzyme inhibitors
  • Formulations of phospholipase enzyme inhibitors

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0176] 1. the preparation of the compound of formula I or formula II

[0177] Compounds of Formula I or II can be readily prepared from commercially available starting materials, compounds known in the literature, or readily available intermediates, using standard synthetic methods and schemes known to those skilled in the art. Standard synthetic methods and procedures for the preparation of organic molecules and functional group transformations and manipulations are readily available from the relevant scientific literature or standard works in the field. It is to be understood that where typical or preferred process conditions (ie, reaction temperatures, times, molar ratios of reactants, solvents, pressures, etc.) are given, other process conditions can also be used unless otherwise stated. Optimum reaction conditions may vary with the particular reactants or solvent used, but those skilled in the art can determine such conditions by routine optimization procedures. Those sk...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention refers to formulations of inhibitors of phospholipase enzymes, such as cytosolic PLA2, compositions containing the same and processes for manufacture thereof.

Description

[0001] Cross References to Related Applications [0002] This application claims the benefit of US Provisional Patent Application No. 60 / 855,569, filed October 31, 2006, which is incorporated herein by reference in its entirety. field of invention [0003] The present invention relates to phospholipases (e.g. cytosolic PLA 2 ) inhibitor formulations, compositions containing the same and methods for their preparation. Background of the invention [0004] Leukotrienes and prostaglandins are important mediators of inflammation, and they participate in the establishment of inflammatory responses in different ways. Leukotrienes recruit inflammatory cells such as neutrophils to sites of inflammation, facilitate extravasation of these cells and stimulate the release of tissue-damaging superoxide and proteases. Leukotrienes also play a pathophysiological role in asthma-induced hypersensitivity [see, eg, B. Samuelson et al., Science, 237:1171-76 (1987)]. Prostaglandins enhance th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4045A61K9/48A61K47/14A61K47/44A61P29/00
CPCA61K47/44A61K31/4045A61K47/14A61K9/4858A61P11/06A61P25/00A61P29/00A61P43/00
Inventor F·A·多纳休M·S·泰斯科尼M·S·库
Owner WYETH LLC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap